Mon. 4 Mar 2024, 6:18am ET
Benzinga
Large Cap, News, Guidance, Health Care, General
The company now estimates it will have approximately 49% of its Medicare advantage members enrolled in plans rated at least 4-star for 2024 star ratings (payment year 2025), based on January 2024 enrollment. The company estimates the financial benefit of the reconsideration decision on payment year 2025 revenue to be approximately $190M